Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 6 | 9 |
| List of Tables | 10 | 2 |
| List of Figures | 12 | 3 |
| Introduction | 15 | 1 |
| Global Active Pharmaceutical Ingredients Market | 16 | 27 |
| Global API Market Overview | 16 | 1 |
| Global API Market Drivers | 16 | 1 |
| Patent Expiries to Change the Dynamics of the Global API Market | 16 | 1 |
| Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for Biomedical Research Set to Boost API Revenues | 16 | 1 |
| Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth | 16 | 1 |
| Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global Pharmaceutical and API Markets | 16 | 1 |
| Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in Underpenetrated Markets | 17 | 1 |
| Global API Market Restraints | 17 | 1 |
| Economic Recession to Restrict Investment in the Pharmaceutical Industry | 17 | 1 |
| Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth Potential | 17 | 1 |
| Increasing Patent Expiries to Impede Growth of the Global API Market | 17 | 1 |
| Regulatory Changes to Delay the Launch of New Drugs | 18 | 1 |
| Global API Market Revenue Analysis and Forecast to 2017 | 19 | 2 |
| Global API Market Revenue Share by Product Type | 21 | 1 |
| Global Synthetic Market Revenue Analysis and Forecast to 2017 | 22 | 2 |
| Global Synthetic Market Revenue Share Analysis by Regions | 24 | 1 |
| Global Synthetics Market Revenue Share Analysis by Region Forecast to 2017 | 25 | 1 |
| Global Synthetic Market Revenue Share Analysis by Customer Base | 26 | 1 |
| Global Synthetic Market Revenue Analysis and Forecast to 2017 | 27 | 2 |
| Global Biotech Market Analysis | 29 | 1 |
| Global Biotech Market Revenue Analysis and Forecast to 2017 | 29 | 2 |
| Global Biotech Market Revenue Share Analysis by Region | 31 | 1 |
| Global Biotech Market Revenue Share Analysis by Region and Forecast to 2017 | 32 | 2 |
| Global Biotech Market Revenue Analysis by Customer Base | 34 | 1 |
| Global Biotech Market Revenue Share Analysis by Customer Base | 34 | 1 |
| Global Biotech Market Revenue Analysis and Forecast to 2017 | 35 | 2 |
| Global Contract Manufacturing Organizations | 37 | 1 |
| Global CMO Outsourcing Process | 38 | 1 |
| Global CMO Market Drivers | 39 | 1 |
| Availability of Low Cost Skilled Manpower | 39 | 1 |
| Global CMO Market Outsourcing Benefits | 40 | 1 |
| Global CMO Market Revenues and Forecast to 2017 | 41 | 2 |
| North America Active Pharmaceutical Ingredients Market | 43 | 41 |
| North America API Market Overview | 43 | 1 |
| North America API Market Drivers | 43 | 1 |
| Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America | 43 | 1 |
| Generic Sector Supports the Growth of the North American API Market | 43 | 1 |
| Increasing Focus on Biological Drugs to Support API Market Revenue Growth | 43 | 1 |
| North American API Market Restraints | 44 | 1 |
| Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth | 44 | 1 |
| High Cost of New Drug Development Hampers Innovation | 44 | 1 |
| Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America | 44 | 1 |
| North America API Market Revenue Analysis and Forecast to 2017 | 45 | 2 |
| North America API Market Revenue Share Analysis by Product Type | 47 | 1 |
| North America Synthetic Market Analysis | 48 | 1 |
| North America Synthetic Market Revenue Analysis and Forecast to 2017 | 48 | 2 |
| North America Synthetic Market Revenue Share Analysis by Countries | 50 | 2 |
| North America Synthetic Market Revenue Share Analysis by Countries and Forecast to 2017 | 52 | 1 |
| North America Synthetic Market Revenue Share Analysis by Customer Base | 53 | 1 |
| North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 | 54 | 2 |
| North America Biotech Market Analysis | 56 | 1 |
| North America Biotech Market Revenue Analysis and Forecast to 2017 | 56 | 2 |
| North America Biotech Market Revenue Share Analysis by Countries | 58 | 2 |
| North America Biotech Market Revenue Share Analysis by Countries and Forecast to 2017 | 60 | 1 |
| North America Biotech Market Revenue Share Analysis by Customer Base | 61 | 1 |
| North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 62 | 2 |
| North America API Market Revenue Share Analysis by Therapeutic Applications | 64 | 1 |
| The US Active Pharmaceutical Ingredients Market | 65 | 1 |
| The US API Market Overview | 65 | 1 |
| The US API Market Revenue by Product Type and Forecast to 2017 | 66 | 2 |
| The US API Market Revenue Share Analysis by Product Type and Forecast to 2017 | 68 | 1 |
| The US API Market by Customer Base | 69 | 1 |
| The US Synthetic Market Revenue by Customer Base and Forecast to 2017 | 69 | 2 |
| The US Synthetic Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 71 | 1 |
| The US Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 72 | 2 |
| The US Biotech Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 74 | 1 |
| Canada Active Pharmaceutical Ingredients Market | 75 | 1 |
| Canada API Market Overview | 75 | 1 |
| Canada API Market Revenue Analysis by Product Type and Forecast to 2017 | 75 | 2 |
| Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017 | 77 | 1 |
| Canada API Market by Customer Base | 78 | 1 |
| Canada Synthetic API Market Revenue Analysis by Customer Base and Forecast by 2017 | 78 | 2 |
| Canada Synthetic Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 80 | 1 |
| Canada Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 81 | 2 |
| Canada Biotech Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 83 | 1 |
| Asia-Pacific Active Pharmaceutical Ingredients Market | 84 | 63 |
| Asia-Pacific API Market Overview | 84 | 1 |
| Asia-Pacific APIs Market Drivers | 85 | 1 |
| Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract API Manufacture | 85 | 1 |
| Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical Industry Growth | 85 | 1 |
| Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market Growth | 85 | 1 |
| Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs | 85 | 1 |
| Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets | 85 | 1 |
| Asia-Pacific API Market Restraints | 86 | 1 |
| Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market | 86 | 1 |
| Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market | 86 | 1 |
| Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential | 86 | 1 |
| Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region | 86 | 1 |
| Asia-Pacific API Market Revenue and Forecasts to 2017 | 87 | 2 |
| Asia-Pacific Revenue Share Analysis by Product Type | 89 | 1 |
| Asia-Pacific Synthetic Market | 90 | 1 |
| Asia-Pacific Synthetic Market Revenues and Forecast to 2017 | 90 | 2 |
| Asia-Pacific Synthetic Market Revenue Share Analysis by Countries | 92 | 2 |
| Asia-Pacific Revenue Share Analysis by Countries | 94 | 1 |
| Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base | 95 | 1 |
| Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 | 96 | 2 |
| Asia-Pacific Biotech Market | 98 | 1 |
| Asia-Pacific Biotech Market Revenues and Forecasts to 2017 | 98 | 2 |
| Asia-Pacific Biotech Market Revenue Share Analysis by Country | 100 | 2 |
| Asia-Pacific Biotech Revenue Share Analysis by Countries | 102 | 2 |
| Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base | 104 | 1 |
| Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 | 105 | 2 |
| Asia-Pacific API Market Share Analysis by Therapeutic Applications | 107 | 1 |
| Japan Active Pharmaceutical Ingredients Market | 108 | 1 |
| Japan API Market Overview | 108 | 1 |
| Japan API Market Revenues and Forecasts to 2017 | 108 | 2 |
| Japan API Market Revenue Share Analysis by Product Type | 110 | 1 |
| Japan API Market by Customer Base | 111 | 1 |
| Japan Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 111 | 2 |
| Japan Synthetic Market Revenue Share Analysis by Customer Base | 113 | 1 |
| Japan Biotech Market Revenue by Customer Base and Forecasts to 2017 | 114 | 2 |
| Japan Biotech Market Revenue Share Analysis by Customer Base | 116 | 1 |
| China Active Pharmaceutical Ingredients Market | 117 | 1 |
| China API Market Overview | 117 | 1 |
| China API Market Revenues by Product Type and Forecasts to 2017 | 118 | 2 |
| China API Market Revenue Share Analysis by Product Types | 120 | 1 |
| China API Market by Customer Base | 121 | 1 |
| China Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 121 | 2 |
| China Synthetic Market Revenue Share Analysis by Customer Base | 123 | 1 |
| China Biotech Market Revenue by Customer Base and Forecast to 2017 | 124 | 2 |
| China Biotech Market Revenue Share Analysis by Customer Base | 126 | 1 |
| South Korea Active Pharmaceutical Ingredients Market | 127 | 1 |
| South Korea API Market Overview | 127 | 1 |
| South Korea APIs Market Revenue and Forecasts to 2017 | 128 | 2 |
| South Korea API Market Revenue Share Analysis by Product Type | 130 | 1 |
| South Korea API Market by Customer Base | 131 | 1 |
| South Korea Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 131 | 2 |
| South Korea Synthetic Market Revenue Share Analysis by Customer Base | 133 | 1 |
| South Korea Biotech Market Revenue by Customer Base and Forecasts to 2017 | 134 | 2 |
| South Korea Biotech Market Revenue Share Analysis by Customer Base | 136 | 1 |
| India Active Pharmaceutical Ingredients Market | 137 | 1 |
| India API Market Overview | 137 | 1 |
| India API Market Revenue and Forecasts to 2017 | 138 | 2 |
| India API Market Revenue Share Analysis by Product Types | 140 | 1 |
| India API Market by Customer Base | 141 | 1 |
| India Synthetic Market Revenue by Customer Base and Forecasts to 2017 | 141 | 2 |
| India Synthetic Market Revenue Share Analysis by Customer Base | 143 | 1 |
| India Biotech Market Revenue by Customer Base and Forecasts to 2017 | 144 | 2 |
| India Biotech Market Revenue Share Analysis by Customer Base | 146 | 1 |
| Europe Active Pharmaceutical Ingredients Market | 147 | 70 |
| Europe API Market Overview | 147 | 1 |
| Europe API Market Drivers | 147 | 1 |
| Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue Growth in Europe | 147 | 1 |
| Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for the European API Market | 147 | 1 |
| Biopharmaceutical Therapies to Support API Market Growth in Europe | 147 | 1 |
| European Regulatory Framework to Facilitate Development of Biosimilars | 147 | 1 |
| Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe | 147 | 1 |
| Europe API Market Restraints | 148 | 1 |
| Increased Consumption of Generics to Limit the Premium Earned from Branded Products | 148 | 1 |
| Increasing Patent Expiries to Hamper the Growth of the European API Market | 148 | 1 |
| Price Cuts to Restrict Revenue Growth for the European API Market | 149 | 2 |
| Europe API Market Revenue Analysis and Forecast to 2017 | 151 | 2 |
| Europe API Market Revenue Share Analysis by Product Type | 153 | 1 |
| Europe Synthetic Market Analysis | 154 | 1 |
| Europe Synthetic Market Revenue Analysis and Forecast to 2017 | 154 | 2 |
| Europe Synthetic Market Revenue Share Analysis by Countries | 156 | 2 |
| Europe Synthetic Market Revenue Share Analysis by Countries and Forecast to 2017 | 158 | 1 |
| European Synthetic Market Revenue Share Analysis by Customer Base | 159 | 1 |
| Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 | 160 | 2 |
| Europe Biotech Market Analysis | 162 | 1 |
| Europe Biotech Market Revenue Analysis and Forecast to 2017 | 162 | 2 |
| Europe Biotech Market Revenue Share Analysis by Countries | 164 | 2 |
| Europe Biotech Market Revenue Share Analysis by Countries and Forecast to 2017 | 166 | 1 |
| Europe Biotech Market Revenue Share Analysis by Customer Base | 167 | 1 |
| Europe Biotech Market Revenues by Customer Base and Forecast to 2017 | 168 | 2 |
| Europe API Market Revenue Share Analysis by Therapeutic Applications | 170 | 2 |
| Germany Active Pharmaceutical Ingredients Market | 172 | 1 |
| Germany API Market Overview | 172 | 1 |
| Germany API Market Revenue Analysis by Product Type and Forecast to 2017 | 172 | 2 |
| Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017 | 174 | 1 |
| Germany API Market by Customer Base | 175 | 1 |
| Germany Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 | 175 | 2 |
| Germany Synthetic Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 177 | 1 |
| Germany Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 178 | 2 |
| Germany Biotech Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 180 | 1 |
| France Active Pharmaceutical Ingredients Market | 181 | 1 |
| France API Market Overview | 181 | 1 |
| France API Market Revenue Analysis by Product Type and Forecast to 2017 | 181 | 2 |
| France API Revenue Share Analysis by Product Type and Forecast to 2017 | 183 | 1 |
| France API Market by Customer Base | 184 | 1 |
| France Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 | 184 | 2 |
| France Synthetic Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 186 | 1 |
| France Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 187 | 2 |
| France Biotech Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 189 | 1 |
| Italy Active Pharmaceutical Ingredients Market | 190 | 1 |
| Italy API Market Overview | 190 | 1 |
| Italy API Market Revenue Analysis by Product Type and Forecast to 2017 | 190 | 2 |
| Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017 | 192 | 1 |
| Italy API Market by Customer Base | 193 | 1 |
| Italy Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 | 193 | 2 |
| Italy Synthetic Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 195 | 1 |
| Italy Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 196 | 2 |
| Italy Biotech Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 198 | 1 |
| The UK Active Pharmaceutical Ingredients Market | 199 | 1 |
| The UK API Market Overview | 199 | 1 |
| The UK API Market Revenue Analysis by Product Type and Forecast to 2017 | 199 | 2 |
| The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017 | 201 | 1 |
| The UK API Market by Customer Base | 202 | 1 |
| The UK Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 | 202 | 2 |
| The UK Synthetic Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 204 | 1 |
| The UK Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 205 | 2 |
| The UK Biotech Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 207 | 1 |
| Spain Active Pharmaceutical Ingredients Market | 208 | 1 |
| Spain API Market Overview | 208 | 1 |
| Spain API Market Revenue Analysis by Product Type and Forecast to 2017 | 208 | 2 |
| Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017 | 210 | 1 |
| Spain API Market by Customer Base | 211 | 1 |
| Spain Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 | 211 | 2 |
| Spain Synthetic Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 213 | 1 |
| Spain Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 | 214 | 2 |
| Spain Biotech Market Revenue Share Analysis by Customer Base and Forecast to 2017 | 216 | 1 |
| Appendix | 217 | 5 |
| Abbreviations | 217 | 1 |
| Bibliography | 218 | 1 |
| Market Definitions | 219 | 1 |
| Methodology | 219 | 2 |
| Coverage | 219 | 1 |
| Secondary Research | 220 | 1 |
| Primary Research | 220 | 1 |
| Expert Panel Validation | 220 | 1 |
| Contact Us | 221 | 1 |
| Disclaimer | 221 | 1 |
